+ All Categories
Home > Documents > 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015...

8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015...

Date post: 13-Jul-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
37
FINANCIAL ANALYST MEETING 2017 8 March 2017
Transcript
Page 1: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

FINANCIAL ANALYST MEETING 20178 March 2017

Page 2: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

DISCLAIMER

3/8/2017 | Page 2

Financial Analyst Meeting 2017

Some of the statements made in this presentation contain forward-looking information

that involve a number of risks and uncertainties.

Such statements are based on a number of assumptions, estimates, projections or plans

that are inherently subject to significant risks, as well as uncertainties and contingencies

that are subject to change. Actual results can differ materially from those anticipated in

the Company´s forward-looking statements as a result of a variety of factors, including

those set forth from time to time in the Company´s press releases and reports and those

set forth from time to time in the Company´s analyst calls and discussions. We do not

assume any obligation to update the forward-looking statements contained in this

presentation.

This presentation does not constitute an offer to sell or a solicitation or offer to buy any

securities of the Company, and no part of this presentation shall form the basis of or may

be relied upon in connection with any contract or commitment. This presentation is being

presented solely for your information and is subject to change without notice.

Page 3: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

AGENDA

3/8/2017 | Page 3

Full-Year Results 2016 – Stefan F. Heidenreich, CEO

Strategy Update

Financials – Jesper Andersen, CFO

Outlook 2017

Q&A

Financial Analyst Meeting 2017

Page 4: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

GROUP KEY FIGURES

Jan. – Dec. 2015 Jan. – Dec. 2016 Change

nominal organic

mill. € mill. € in % in %

Sales 6,686 6,752 1.0 3.2

EBIT 962 1,015

Profit after Tax 671 727

Earnings per Share in € 2.91 3.13

EBIT* 962 1,015

Profit after Tax* 671 727

EBIT Margin* 14.4% 15.0%

Profit after Tax Margin* 10.0% 10.8%

Earnings per Share in €* 2.91 3.13

3/8/2017

Financial Analyst Meeting 2017

| Page 4

* Excluding special factors.

Page 5: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

3/8/2017 | Page 5

Financial Analyst Meeting 2017

GROWTH

Net Sales Growth in % vs. PY

CONSUMER SALES

3.63.1 2.9

3.63.3

3.6

4.3

Q3 2016Q2 2016

4.03.8

4.4

Q1 2016FY 2015 Q4 2016

4.1

FY 2016

* Consumer organic sales growth if sales in Argentina had been calculated at constant FX rates

Page 6: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

3/8/2017 | Page 6

Financial Analyst Meeting 2017

EBIT

In % of NS, Consumer, excl. special factors, FY

CONSUMER EBIT

12.0

12.5

13.0

14.8

13.9

11.4

20162014201320122011 2015

Page 7: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

CONSUMER SALES PER REGION

Jan. – Dec. 2015 Jan. – Dec. 2016 Change

nominal organic

mill. € mill. € in % in %

Europe 2,816 2,801 -0.6 2.0

Western Europe 2,281 2,262 -0.8 1.0

Eastern Europe 535 539 0.6 6.6

Americas 1,076 1,078 0.2 2.9

North America 426 432 1.4 1.6

Latin America 650 646 -0.7 3.7

Africa/Asia/Australia 1,654 1,727 4.4 5.7

Total Consumer 5,546 5,606 1.1 3.3

3/8/2017

Financial Analyst Meeting 2017

| Page 7

Page 8: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

TESA KEY FIGURES

Jan. – Dec. 2015 Jan. – Dec. 2016 Change

nominal like-for-like

mill. € mill. € in % in %

Sales 1,140 1,146 0.6 2.6

EBIT* 191 186

EBIT Margin* 16.8% 16.2%

3/8/2017

Financial Analyst Meeting 2017

| Page 8

* Excluding special factors

Page 9: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

BLUE FOCUS

2012-2016

3/8/2017

Financial Analyst Meeting 2017

| Page 9

Page 10: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

BLUE AGENDA

3/8/2017

Financial Analyst Meeting 2017

| Page 10

Page 11: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

BLUE AGENDA PILLARS

3/8/2017 | Page 11

Financial Analyst Meeting 2017

BRAND EFFICIENCYFOOTPRINTINNOVATION PEOPLE

48%52%

Page 12: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

BLUE AGENDA – BRAND

3/8/2017 | Page 12

Financial Analyst Meeting 2017

MOST TRUSTED GLOBAL

SKIN CARE BRAND

SIGNIFICANT

IMPROVEMENT IN

BRAND HEALTH

Page 13: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

BLUE AGENDA – INNOVATION

3/8/2017 | Page 13

Financial Analyst Meeting 2017

STRONG INNOVATIONS

OVER THE PAST YEARS

BREAKTHROUGH

PIPELINE FOR

2017 & 2018

Page 14: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

BLUE AGENDA – FOOTPRINT

3/8/2017 | Page 14

Financial Analyst Meeting 2017

54%46%

SUCCESSFULLY

GROWING IN EMERGING

MARKETS

WHITE SPACE FOR

FURTHER EXPANSION

52%48%

Western Europe, North America

Eastern Europe, Latin America, A/A/A

Page 15: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

BLUE AGENDA – EFFICIENCY

3/8/2017 | Page 15

Financial Analyst Meeting 2017

In % of NS

WORKING CAPITAL

CFO (5/2015)

Prior 20 years

with Colgate-

Palmolive

CSCO (6/2015)

Prior 5 years

with Unilever

and 13 years

with Mars

JESPER

ANDERSEN

HARALD

EMBERGER

EFFICIENCY AS CORE

FUEL FOR GROWTH

INCREASING SPEED AND

AGILITY

2016

11.0

14.6

20152014

13.6

Page 16: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

BLUE AGENDA – PEOPLE

3/8/2017 | Page 16

Financial Analyst Meeting 2017

FASTEST ENGAGEMENT

INCREASE IN CONSUMER

INDUSTRY

100% COMMITTED TO

CORE VALUES

Page 17: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

BLUE AGENDA – PERFORMANCE

3/8/2017 | Page 17

Financial Analyst Meeting 2017

2012

12.0 12.5

2011

11.4

2016

14.8

2014

13.9

2013

13.0

2015

CASH

2011 2016

COMPANY VALUESHARE PRICE

20162011

Beiersdorf:

+94%

DAX:

+66%

20.311

2011 2016

10.466

2011

CAGR 4.7%

2016

PROFITABILITYGROWTH

2.2 bEUR

3.7 bEUR

Page 18: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

INTO THE FUTURE

2017+

3/8/2017

Financial Analyst Meeting 2017

| Page 18

Page 19: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

OUR FUTURE IS GROWTH

3/8/2017 | Page 19

Financial Analyst Meeting 2017

BREAKTHROUGH

INNOVATION

GLOBAL LEADER

MEN

MORE LOCAL

FOOTPRINT

NEW GROWTH

PLATFORMS

DIGITAL

ACCELERATION

Page 20: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

FUTURE – BREAKTHROUGH INNOVATION

3/8/2017 | Page 20

Financial Analyst Meeting 2017

>40% OF CONSUMERS

ANNOYED BY UV FILTER

STAINS

FIRST EVER SUNSCREEN

TO PROTECT CLOTHES

DISRUPTION OF

SUN CARE CATEGORY

Page 21: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

FUTURE – GLOBAL LEADER MEN

3/8/2017 | Page 21

Financial Analyst Meeting 2017

5.4

9.8

11.2

Source: Euromonitor, Categories Men's Skin Care, Men's Pre-Shave, Men's Post-Shave, Men's Bath and Shower

In %

GLOBAL MARKET SHARE MEN

LARGE PART OF NIVEA

BUSINESS TODAY WITH

MEN, GROWING QUICKLY

LONG-TERM

PARTNERSHIP WITH

WORLD SOCCER CLUBS

Page 22: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

FUTURE – MORE LOCAL FOOTPRINT

3/8/2017 | Page 22

Financial Analyst Meeting 2017

FIRST EVER AEROSOL

PLANT OUTSIDE EUROPE

STRENGTHEN FOOTPRINT

IN STRATEGIC REGION

STRONG #2 POSITION IN

BRAZIL AND ARGENTINA

ITATIBA

Page 23: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

FUTURE – DIGITAL ACCELERATION

20%

NEW CDO

Digital IQ: 145

NEW CDO

DIGITAL

MARKETING

E-COMMERCE

CAPABILITIES

3/8/2017

Financial Analyst Meeting 2017

| Page 23

Page 24: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

FUTURE – GROWTH PLATFORMS

3/8/2017 | Page 24

Financial Analyst Meeting 2017

New Board Member

Prior Senior Vice

President Global

Consumer Health Care at

Sanofi

Before 15 years with

L‘Oreal in Consumer and

Pharma division

VINCENT WARNERY

Page 25: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

AGENDA

3/8/2017 | Page 25

Full-Year Results 2016 – Stefan F. Heidenreich, CEO

Strategy Update

Financials – Jesper Andersen, CFO

Outlook 2017

Q&A

Financial Analyst Meeting 2017

Page 26: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

GROWTH

provides the fuel for growth

is our priority

EFFICIENCY TO FUEL GROWTH

3/8/2017

Financial Analyst Meeting 2017

| Page 26

Page 27: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

• Quality of sales

• Competitive pricing

• Promotion effectiveness

ROLE LEVERS

FINANCIAL FRAMEWORK

3/8/2017 | Page 27

SALES

GROWTH

Profitable

growth

MARGINSSource of

funds

• Mix and assortment

• Cost efficiency

• Pricing

MARKETING

BUDGET

Invest &

Build Brands

• Competitive media spend

• Digital investment

• Efficient spending

GENERAL

EXPENSES

Source of

funds

• Cost discipline

• Optimized structures

• Building new capabilities

EBITGradual

improvement

• Geographic balance

• Long term improvement

WORKING

CAPITAL

Business

building

• Improve WOC

• Efficiency measure

• Speed and agility

Financial Analyst Meeting 2017

Page 28: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

EFFICIENCY PROGRAM

3/8/2017 | Page 28

Financial Analyst Meeting 2017

LOGISTICS

PROCUREMENT

MARGIN

GENERAL EXPENSE

ASSORTMENT WOC

DASHBOARD

ACHIEVEMENT

MARGINGROSS SAVINGS

100mEUR +60bpt

ASSORTMENT WORKING CAPITAL

>10% NS/SKU -260bpt

Consumer Segment

Page 29: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

GROUP GROSS MARGIN

3/8/2017 | Page 29

Price

+0.4%

Gross Margin

FY 2015

-0.7%

Gross Margin

FY 2016

58.9%

FXCosts &

Logistics

+0.9%

58.3%

Our efficiency program is driving the gross margin expansion.

Financial Analyst Meeting 2017

Page 30: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

3/8/2017

Financial Analyst Meeting 2017

| Page 30

CONSUMER WORKING CAPITAL

14.6

FY 2014

11.0

FY 2016

13.6

11.5

Q1 2016 H1 2016 9M 2016

12.3

13.0

FY 20159M 2015

14.1

H1 2015

14.4

Working capital in % of Consumer sales on a 12-month rolling basis

Page 31: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

3/8/2017 | Page 31

Financial Analyst Meeting 2017

EBIT

In % of NS, Consumer, excl. special factors, FY

CONSUMER EBIT

20162015

13.9

2014

14.8

11.4

2011

12.5

13.0

2012 2013

12.0

Page 32: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

GROUP PROFIT AFTER TAX

3/8/2017 | Page 32

Financial Analyst Meeting 2017

2015

14.4%

2016

15.0%

+60bps

2016

10.8%

2015

10.0%

+80bps

EBIT Profit after Tax

Optimization of net interest and improving tax rate by 60bps to 30.1%.

Page 33: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

3/8/2017 | Page 33

Financial Analyst Meeting 2017

GROUP NET LIQUIDITY

2,222

20122011

2,436

2016

2,5272,529

2013

3,708

20152014

3,036

(in mill. €)

Page 34: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

GUIDANCE 2017

2016 data for reference (excluding special factors):

Consumer EBIT 14.8%

tesa EBIT 16.2%

Group EBIT 15.0%

Group Profit After Tax Margin 10.8%

Consumer

Sales growth 3-4%

EBIT margin slightly above previous year

tesa

Sales growth 3-4%

EBIT margin slightly below previous year

Total Group

Sales growth 3-4%

EBIT margin slightly above

previous year

PAT margin slightly above

previous year

3/8/2017

Financial Analyst Meeting 2017

| Page 34

Note: Sales development on an organic basis – Profit development on an operative basis

Page 35: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

FINANCIAL ANALYST MEETING 2017

3/8/2017 | Page 35

Financial Analyst Meeting 2017

Questions and Answers

Page 36: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

INVESTOR RELATIONS CONTACT

3/8/2017 | Page 36

Financial Analyst Meeting 2017

Beiersdorf Website

www.Beiersdorf.com

IR-Hotline

Tel: +49 (0) 40 4909 5000

Fax: +49 (0) 40 4909 18 5000

Email: [email protected]

Page 37: 8 March 2017 - Beiersdorf/media/Beiersdorf/...Mar 08, 2017  · Q2 2016 Q3 2016 4.0 3.8 4.4 FY 2015 Q1 2016 Q4 2016 4.1 ... Sanofi Before 15 years with L‘Orealin Consumer and Pharma

FINANCIAL ANALYST MEETING 20178 March 2017


Recommended